Company Filing History:
Years Active: 2012-2013
Title: A-yeon Cho: Innovator in Biopharmaceuticals
Introduction
A-yeon Cho is a prominent inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of biopharmaceuticals, holding a total of 4 patents. His work focuses on developing innovative solutions that target critical pathways in human health.
Latest Patents
A-yeon Cho's latest patents include groundbreaking research on polypeptides and antibodies. One of his notable patents is for polypeptides specifically binding to vascular endothelial growth factor receptor-2. This invention includes a polypeptide that inhibits the binding between vascular endothelial growth factor receptor-2 and a vascular endothelial growth factor, along with a fusion protein that incorporates this polypeptide. Another significant patent involves an antibody specifically binding to angiopoietin-2, which includes antigen-binding fragments and outlines its various uses.
Career Highlights
A-yeon Cho is currently employed at Samsung Electronics Co., Ltd., where he continues to push the boundaries of innovation in biopharmaceuticals. His work has not only advanced scientific understanding but also has the potential to lead to new therapeutic options for patients.
Collaborations
Some of A-yeon Cho's notable coworkers include Jong-sang Ryu and Min-Kyung Kim. Their collaborative efforts contribute to the dynamic research environment at Samsung Electronics Co., Ltd.
Conclusion
A-yeon Cho exemplifies the spirit of innovation in the biopharmaceutical industry. His patents and ongoing research are paving the way for future advancements in medical treatments.